España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Arrowhead Pharma
ARWR
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$19.88
-0.35
-1.73%
At close: -
$19.87
-0.01000
-0.05%
After Hours: 4:53 PM EDT
Get Report
Comment
Q1 2025 Earnings in 9 days from now on Mon Feb 10th, after the market close
Arrowhead Pharma (ARWR) Forecast
News
Earnings
Arrowhead Pharma (ARWR) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Arrowhead Pharma (NASDAQ:ARWR) Stock
Arrowhead Pharma Stock (NASDAQ: ARWR)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, January 23, 2025
HC Wainwright & Co. Reiterates Buy on Arrowhe...
Benzinga Newsdesk
Wednesday, January 22, 2025
Arrowhead Pharmaceuticals To Replace Barnes ...
Benzinga Newsdesk
Guidewire Software To Replace Arrowhead Pharm...
Benzinga Newsdesk
Friday, January 17, 2025
Arrowhead Pharmaceuticals Announces FDA Accep...
Benzinga Newsdesk
Friday, December 20, 2024
HC Wainwright & Co. Reiterates Buy on Arrowhe...
Benzinga Newsdesk
Thursday, December 12, 2024
Chardan Capital Maintains Buy on Arrowhead Ph...
Benzinga Newsdesk
Wednesday, December 11, 2024
Arrowhead Pharmaceuticals Announced Interim R...
Benzinga Newsdesk
Tuesday, December 03, 2024
HC Wainwright & Co. Maintains Buy on Arrowhea...
Benzinga Newsdesk
Arrowhead Pharmaceuticals Has Filed A Request...
Benzinga Newsdesk
Sunday, December 01, 2024
Archer Aviation, Hims & Hers Health And Urban Outfitters Are Among Top 8 Mid-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
Lekha Gupta
Rivian Automotive, Rocket Lab And Moderna Are Among Top 10 Large-Cap Gainers Last Week (Nov 25-Nov 29): Are The Others In Your Portfolio?
Lekha Gupta
Friday, November 29, 2024
Bernstein Maintains Market Perform on Arrowhe...
Benzinga Newsdesk
Wednesday, November 27, 2024
Iris Energy, Arrowhead Pharmaceuticals, Urban Outfitters And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
Piper Sandler Maintains Overweight on Arrowhe...
Benzinga Newsdesk
Citigroup Maintains Neutral on Arrowhead Phar...
Benzinga Newsdesk
Arrowhead Pharmaceuticals shares are trading ...
Benzinga Newsdesk
Chardan Capital Maintains Buy on Arrowhead Ph...
Benzinga Newsdesk
Tuesday, November 26, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Arrowhead Pharma FY 2024 GAAP EPS $(5.00) Mis...
Benzinga Newsdesk
Arrowhead Pharmaceuticals Shares Are On The Rise Today: What's Going On?
Vaishali Prayag
J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Avi Kapoor
Arrowhead Pharmaceuticals shares are trading ...
Benzinga Newsdesk
Earnings Scheduled For November 26, 2024
Benzinga Insights
Monday, November 25, 2024
A Look Ahead: Arrowhead Pharma's Earnings Forecast
Benzinga Insights
Monday, November 18, 2024
Arrowhead Pharmaceuticals Submits New Drug Ap...
Benzinga Newsdesk
Friday, October 11, 2024
HC Wainwright & Co. Reiterates Buy on Arrowhe...
Benzinga Newsdesk
Tuesday, October 08, 2024
Piper Sandler Reiterates Overweight on Arrowh...
Benzinga Newsdesk
Thursday, September 26, 2024
RBC Capital Reiterates Outperform on Arrowhea...
Benzinga Newsdesk
Monday, September 23, 2024
Arrowhead Pharmaceuticals Files for Phase 1/2...
Benzinga Newsdesk
Tuesday, September 10, 2024
The FDA Granted Breakthrough Therapy Designat...
Benzinga Newsdesk
Monday, September 09, 2024
Cantor Fitzgerald Reiterates Overweight on Ar...
Benzinga Newsdesk
Thursday, September 05, 2024
HC Wainwright & Co. Reiterates Buy on Arrowhe...
Benzinga Newsdesk
Tuesday, September 03, 2024
HC Wainwright & Co. Reiterates Buy on Arrowhe...
Benzinga Newsdesk
Arrowhead Pharmaceuticals shares are trading ...
Benzinga Newsdesk
Arrowhead's Plozasiran Meets All Primary and ...
Benzinga Newsdesk
Wednesday, August 21, 2024
Arrowhead Pharmaceuticals Announced That It W...
Benzinga Newsdesk
Wednesday, August 14, 2024
Arrowhead Pharmaceuticals To Advance Two New ...
Benzinga Newsdesk
Monday, August 12, 2024
B. Riley Securities Reiterates Buy on Arrowhe...
Benzinga Newsdesk
Friday, August 09, 2024
Arrowhead Pharmaceuticals shares are trading ...
Benzinga Newsdesk
Thursday, August 08, 2024
Arrowhead Pharmaceuticals Announces $500M Str...
Benzinga Newsdesk
Arrowhead Pharma Q3 2024 Revenue $0 Down From...
Benzinga Newsdesk
Arrowhead Pharma Q3 2024 GAAP EPS $(1.38) Mis...
Benzinga Newsdesk
Tuesday, July 23, 2024
HC Wainwright & Co. Reiterates Buy on Arrowhe...
Benzinga Newsdesk
Wednesday, July 17, 2024
Chardan Capital Maintains Buy on Arrowhead Ph...
Benzinga Newsdesk
Friday, July 05, 2024
S&P Global To Rally More Than 13%? Here Are 10 Top Analyst Forecasts For Friday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Arrowhea...
Benzinga Newsdesk
Wednesday, June 26, 2024
Chardan Capital Maintains Buy on Arrowhead Ph...
Benzinga Newsdesk
Tuesday, June 25, 2024
Arrowhead Pharmaceuticals To Advance Investig...
Benzinga Newsdesk
Monday, June 24, 2024
Why Arrowhead Pharmaceuticals (ARWR) Stock Is Seeing Blue Skies
Henry Khederian
Arrowhead Pharmaceuticals shares are trading ...
Benzinga Newsdesk
Show More